Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of chromatin remodeling factor CHD5 expression in gastric cancer

21 Nov 2019

Abstract excerpt

Chromodomain helicase DNA‑binding 5 (CHD5), which is a member of the CHD family, has been identified as a tumor suppressor gene in a variety of malignancies. The aim of the current study was to clarify the clinical significance of CHD5 expression in gastric cancer. CHD5 expression was evaluated using immunohistochemistry (IHC) in 154 specimens resected from patients with gastric cancer from January 2011 to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Chromatin Remodeling and Cancer
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31897220
DOI: 10.3892/ol.2019.11138

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of chromatin remodeling factor CHD5 expression in gastric cancerPMID 31897220Read ↗

CHD5 is down-regulated through promoter hypermethylation in gastric cancerSemantic proximity Read ↗

Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancerSemantic proximity Read ↗

Role of CHD5 in Human Cancers: 10 Years LaterSemantic proximity Read ↗

Cadherin 5 expression correlates with poor survival in human gastric cancerSemantic proximity Read ↗

Molecular characteristics and oncogenic role of CHD family genes: a pan-cancer analysis based on bioinformatic and biological analysis.Semantic proximity Read ↗

Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for GliomaSemantic proximity Read ↗

Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human gliomaSemantic proximity Read ↗

CHD5 may be a promising novel bio-marker for the diagnosis of lung cancer patientsSemantic proximity Read ↗

CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5ASemantic proximity Read ↗

The therapeutic potential of targeting the CHD protein family in cancer.Semantic proximity Read ↗

Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7.Semantic proximity Read ↗

Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.